Google's Gemini 2.0 AI tool aims to enhance scientific research by proposing hypotheses and research plans through a reasoning process based on debates among its agents. Despite initial enthusiasm from some researchers who believe it could transform science, many experts express skepticism. Critics argue that the AI's outputs are too vague to be taken seriously and question the novelty of its drug repurposing claims. This skepticism may hinder the AI's acceptance and integration into the scientific process, as established researchers see little demand for such tools.
The Gemini 2.0 AI is said to offer "superpowers" to scientists, yet skepticism prevails regarding its practical applications in hypothesis generation.
"This preliminary tool, while interesting, doesn't seem likely to be seriously used," stated a computer vision researcher, reflecting doubts within the scientific community.
Critics highlight that the AI's claims about novel drug repurposing lack sufficient detail for scientists to consider them valuable.
Google's assertion of novel insights into drug treatment has been challenged, with experts noting that identified drugs are already well understood.
Collection
[
|
...
]